HDAC4 and myocardial infarction: Transgenic OE of HDAC4 in cardiomyocytes with αMHC promoter impaired cardiac contraction and exacerbated contractile dysfunction on MI, as well as impaired ventricular functional recovery following I/R injury (Zhang L. et al., 2018; Zhang LX.